WAYLAND, Mass.--(BUSINESS WIRE)--Candela Corporation (NASDAQ:CLZR) announced today the
introduction of the new QuadraLASE(TM) laser. The QuadraLASE
system combines the proven performance of a CO2 laser with an
innovative scanning system giving practitioners a total solution
for skin rejuvenation* and tightening** by treating wrinkles, uneven
tone and texture, sun damage, acne scarring, the removal of skin tags,
benign lesions and more. The Company will begin sales and marketing
activities around the world with launch at the Annual Meeting of the
American Academy of Dermatology, which takes place in San Francisco from
March 6-10, 2009, and will commence shipments in March.
The QuadraLASE system utilizes the unique patent pending QuadraSCAN(TM)
technology, which minimizes heat build-up in the skin, resulting in
increased patient comfort. In addition, the system is engineered to fit
the needs of every aesthetic practice offering:
Value with no disposables - keeping long-term operating costs down.
Choice of QS and QD handpieces providing true variable depth ablation.
Elegant design and small footprint minimizing the need for space.
Renowned Candela after-the-sale support.
"We are excited to be offering a unique solution for fractional
ablation, one of the fastest growing segments of the aesthetic market,"
said Catherine A. Kniker, Senior Vice President of Marketing and
Corporate Development. "We recognized the restrictions of fractional
lasers and are now offering our QuadraLASE system to
deliver a more desirable experience to patients and physicians. This
advanced skin rejuvenation device will bring a whole new dimension to
aesthetic medicine allowing practitioners to diversify treatment
capabilities with a single device."
Kniker continued, "Candela has consistently developed gold standard
products to treat the most popular applications, including leg and
facial vein removal, skin rejuvenation and tightening, permanent hair
reduction, tattoo and pigmented lesion removal and acne reduction. With
the QuadraLASE system joining our suite of lasers, we now
have the most comprehensive best-in-class solutions in tattoo removal expert the market."
Thomas E. Rohrer, M.D., SkinCare Physicians of Chestnut Hill (MA), who
performed some of the studies, stated, "Based on my clinical experience
with the QuadraLASE system, this device is very versatile,
easy-to-use and comfortable for the patient, and it delivers excellent
About QuadraLASE: The new QuadraLASE
fractional laser features proprietary QuadraSCAN technology,
which reduces heat build-up in the skin, resulting in increased patient
comfort. Candela QuadraLASE offers performance,
versatility and value in a fractional CO2 laser. For more
information please visit www.quadralase.com
or call 800-733-8550 ext. 247.
* Skin rejuvenation through skin resurfacing.
** Skin tightening through wrinkle reduction.
QuadraLASE and QuadraSCAN are trademarks, and Candela is a registered
trademark of Candela Corporation.
Candela Corporation manufactures and distributes innovative clinical
solutions that enable physicians, surgeons, and personal care
practitioners to treat selected cosmetic and medical conditions using
lasers, aesthetic laser systems, and other advanced technologies.
Founded near Boston in 1970, Candela markets and services its products
in 86 countries from offices and distributors in the United States,
Europe, Japan, China and other Asian locations. Candela established the
aesthetic laser market 20 years ago, and currently has an installed base
of over 13,500 systems worldwide. Visit Candela on the Web at http://www.candelalaser.com.
Safe Harbor Statement:
Except for the historical information contained herein, this news
release contains forward-looking statements that constitute Candela
Corporation's current intentions, hopes, beliefs, expectations or
predictions of the future, which are therefore inherently subject to
risks and uncertainties. These statements include declarations regarding
our or our management's beliefs and current expectations. In some cases,
you can identify forward-looking statements by terminology such as
"may," "will," "should," "expects," "plans," "anticipates," "believes,"
"estimates," "predicts," "potential" or "continue" or the negative of
such terms or other comparable terminology. These forward-looking
statements are subject to inherent risks and uncertainties in predicting
future results and conditions that could
cause the actual results to differ materially from those projected in
these forward-looking statements. The risks and uncertainties that may
affect forward-looking statements include, among others: the
availability of, and our ability to successfully implement strategic and
operational alternatives, the pendency of re-examinations of the '844
Patent and the '568 Patent tattoo removal expert before the PTO, our alleged infringement of
the '844 Patent and the '568 Patent, the validity of the '844 Patent and
the '568 Patent, our expected legal expenses, our exploration of
strategic and operational alternatives, the expected recovery of our
industry, our future revenue, gross margin, expense levels Ink Revision tattoo removal and earnings,
our growth prospects, market acceptance of our products, the strength of
our distribution channels, our ability to add new products, our ability
to expand regulatory approvals and the liquidity of our common stock,
the cancellation or deferral of customer orders, the risk of a material
adverse judgment or increased litigation-related expenses in pending
litigation matters, dependence on a small number of strategic
distribution relationships, difficulties in the timely development and
market acceptance of new products, unanticipated increases in expenses,
market developments that vary from the current public expectations
concerning the growth of the laser industry, increased competitive
pressures, changes in economic conditions, or difficulties in obtaining
timely regulatory approvals. Further information on factors that could
affect Candela's performance is included in Candela's periodic reports
filed with the SEC. Candela cautions readers not to place undue reliance
upon any such forward-looking statements, which speak only as of the
date made. Candela expressly disclaims any obligations or undertaking to
release publicly any updates or revisions to any such statements to
reflect any change in Candela's expectations or any change in events,
conditions or circumstances on which any such statement is based.